Dimensional Fund Advisors LP Immunovant, Inc. Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Immunovant, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 374,285 shares of IMVT stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

374,285

Previous 236,966 57.95%

Holding current value

$10.3 Million

Previous $6.52 Million 57.96%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	N/A	137,319 Added 57.95%	374,285 $10.3 Million
Q2 2025 Aug 12, 2025	SELL	N/A	-157,970 Reduced 40.0%	236,966 $6.52 Million
Q1 2025 May 13, 2025	SELL	N/A	-8,811 Reduced 2.18%	394,936 $10.9 Million
Q4 2024 Feb 13, 2025	SELL	N/A	-58,463 Reduced 12.65%	403,747 $11.1 Million
Q3 2024 Nov 07, 2024	SELL	$27.51 - $27.51 $893,497 - $893,497	-32,479 Reduced 6.57%	462,210 $12.7 Million

Q2 2024 Aug 09, 2024	SELL	$25.1 - $31.61 $1.98 Million - $2.49 Million	-78,758 Reduced 13.73%	494,689 $13.1 Million
Q1 2024 May 10, 2024	SELL	$30.27 - $43.79 $4.19 Million - $6.07 Million	-138,503 Reduced 19.45%	573,447 $18.5 Million
Q4 2023 Feb 07, 2024	SELL	$31.31 - $44.19 $769,568 - $1.09 Million	-24,579 Reduced 3.34%	711,950 $30 Million
Q3 2023 Nov 09, 2023	SELL	$18.55 - $39.96 $2.49 Million - $5.36 Million	-134,168 Reduced 15.41%	736,529 $28.3 Million
Q2 2023 Aug 09, 2023	SELL	$14.2 - $23.75 $2.29 Million - $3.83 Million	-161,266 Reduced 15.63%	870,697 $16.5 Million
Q1 2023 May 12, 2023	SELL	$15.27 - $19.72 $4.06 Million - $5.24 Million	-265,645 Reduced 20.47%	1,031,963 $16 Million
Q4 2022 Feb 09, 2023	BUY	$6.59 - $17.75 $1.58 Million - $4.24 Million	239,149 Added 22.59%	1,297,608 $23 Million
Q3 2022 Nov 10, 2022	BUY	$3.93 - $6.37 $444,007 - $719,676	112,979 Added 11.95%	1,058,459 $5.91 Million
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $860,260 - $1.44 Million	254,515 Added 36.83%	945,480 $3.69 Million
Q1 2022 May 13, 2022	BUY	$5.06 - $8.77 $2.09 Million - $3.62 Million	412,997 Added 148.58%	690,965 $3.81 Million
Q4 2021 Feb 09, 2022	BUY	$7.33 - $9.32 $1.94 Million - $2.46 Million	264,230 Added 1923.35%	277,968 $2.37 Million
Q3 2021 Nov 12, 2021	BUY	$7.01 - $11.37 $96,303 - $156,201	13,738 New	13,738 $119,000

Others Institutions Holding IMVT

# of Institutions

212

Shares Held

81M

Call Options Held

557K

Put Options Held

704K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Immunovant, Inc. Transaction History